Careers

EN | JP

News & Events

News & Events

Home >  News & Events

Article Type

View All
eBook
Events
Investor Relations
Financial Statement
Independent Auditor’s Report
IR News
Presentations
News
Press Release
Webinar

Year

2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
Press Release
Notice regarding Designation as an Orphan Drug and Supplemental New Drug Application for Sodium Phenylbutyrate
Download
Press Release
CMIC Partners with the Japanese Society for Inherited Metabolic Diseases to Address “Drug Loss” in Japan
Download
Events
The 40th Annual Meeting of the Japanese Society for the Study of Xenobiotics
Events
Regenerative Medicine Japan 2025
News
CMIC Achieves CyberVadis’ Platinum Rating for Second Consecutive Year
Press Release
CMIC Group Acquires SBT Certification of Its GHG Reduction Targets  — Driving Forward Its Decarbonization Commitment
Events
AAPS PharmSci 360
Events
ChemOutsourcing
Events
COG Europe 2025
Events
COG Bay Area 2025
Events
5th Annual Oligonucleotides for CNS Summit
Events
BIO Asia-Taiwan 2025
News
CMIC Featured by Clinical Trials Arena for Leadership in Japan’s Clinical Trial Landscape: Insights from OCT UK & Ireland
Events
“The 17th Nakamura Keith Haring Collection International Children’s Drawing Contest” Call for entries
News
Notice Regarding the Relocation Date of CMIC Group Headquarters
Events
The 52nd Annual Meeting of the Japanese Society of Toxicology
News
Fette Compacting and CMIC Enter into Strategic Partnership
Events
Outsourcing in Clinical Trials New England 2025
Events
Interphex 2025
Events
BIO-Europe Spring 2025
Events
19th Annual WRIB 2025
Press Release
CMIC HOLDINGS and Blackstone Agreed to a Strategic Equity Alliance in CRO Business
Events
JSMO 2025
Events
DCAT Week 2025
Press Release
CMIC Introduces UltraIntake, a New Tool to Streamline Drug Safety Information Management
Download
Events
Japanese Safety Pharmacology Society, 16th Annual Meeting
Events
Outsourcing in Clinical Trials UK & Ireland 2025
Events
Fierce JPM Week 2025
Press Release
Announcement Regarding the Designation of Glycerol Phenylbutyrate as an Orphan Drug
Press Release
Announcement of Application for Approval of Glycerol Phenylbutyrate for the Treatment of Urea Cycle Disorder
CMIC logo

Solutions

About CMIC

Locations

Contact

Resources

Careers

© CMIC HOLDINGS Co., LTD. All rights reserved.

Join our
mailing list

Never miss an update – Click below to receive emails on CMIC‘s global services, latest news, & more!

Click Here to Sign Up
EN  |  JP
Go to Top